---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-21-005860"
form_type: "8-K"
ticker: "XBIO"
cik: "0001534525"
company_name: "Xenetic Biosciences, Inc."
filed_at: "2021-11-19T23:59:59+00:00"
generated_at: "2026-06-28T06:32:52.131252+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Xenetic Biosciences enters $4M ATM equity offering with H.C. Wainwright

## Summary
- Entered ATM Agreement with H.C. Wainwright as exclusive agent to sell up to $4M of common stock.
- Shares sold at-the-market on Nasdaq; Wainwright receives 3% commission on gross proceeds.
- Company has no obligation to sell any shares and may suspend or terminate the agreement.
- Agreement effective November 19, 2021; filed as Exhibit 1.1 to the 8-K.

## SEC filing metadata
- accession: 0001683168-21-005860
- form_type: 8-K
- ticker: XBIO
- cik: 0001534525
- company_name: Xenetic Biosciences, Inc.
- filed_at: 2021-11-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/0001683168-21-005860-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534525/000168316821005860/xenetic_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-21-005860
- JSON: https://secwatch.observer/filing/0001683168-21-005860.json
- Plain text: https://secwatch.observer/filing/0001683168-21-005860.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.